Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction.
Goldberg
Lee R
LR
University of Pennsylvania School of Medicine, Philadelphia, PA 19104. lee.goldberg@uphs.upenn.edu
Jessup
Mariell
M
D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers; D002317:Cardiovascular Agents / Q000145:classification / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000150:complications; D017147:Defibrillators, Implantable; D048909:Diabetes Complications / Q000628:therapy; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D006306:Health Surveys; D006333:Heart Failure / Q000145:classification / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D006801:Humans; D006973:Hypertension / Q000150:complications; D017379:Hypertrophy, Left Ventricular / Q000150:complications; D008297:Male; D008403:Mass Screening; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D020097:Natriuretic Peptide, Brain / Q000097:blood; D010138:Pacemaker, Artificial; D017410:Practice Guidelines as Topic; D015995:Prevalence; D012720:Severity of Illness Index; D013318:Stroke Volume; D013599:Systole; D016896:Treatment Outcome; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D020257:Ventricular Remodeling
D015415:Biomarkers; D002317:Cardiovascular Agents; D020097:Natriuretic Peptide, Brain